Hydroxytyrosol and Brain Tumors: Mechanisms of Action and Therapeutic Potential
Open Access
- 18 August 2025
- journal article
- review article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 47 (8) , 667
Abstract
Central nervous system (CNS) tumors, especially gliomas and IDH-wildtype glioblastoma, present high aggressiveness, low response to current treatments and limited survival. Several biological processes such as oxidative stress, inflammation, apoptosis, and autophagy are involved in their development. Hydroxytyrosol (HTX), a phenolic compound present in olives, has shown relevant effects on these processes in experimental models. This review analyzes its chemical characteristics, bioavailability, and ability to cross the blood–brain barrier, as well as its mechanisms of action. Despite its rapid metabolism, HTX can reach the brain in small but functional amounts, and various formulation methods can enhance its delivery to nervous tissue. HTX acts on cellular pathways such as Nrf2, NF-κB, JAK/STAT, PI3K/Akt and SIRT1, regulating redox balance, inflammation, programmed cell death, and autophagy. It can also influence gene expression through epigenetic mechanisms. In cell models, it has shown inhibitory effects on tumor growth and activation of apoptosis, without affecting non-tumor cells. These results support its possible usefulness as an adjunct in the treatment of brain tumors, although further studies in animal and human models are required.Keywords
This publication has 122 references indexed in Scilit:
- The curse of blood–brain barrier and blood–tumor barrier in malignant brain tumor treatmentInternational Journal of Clinical Oncology, 2025
- Advancing medulloblastoma therapy: strategies and survival insightsClinical and Experimental Medicine, 2025
- Regulation of Glycolysis by SMAD5 in Glioma Cells: Implications for Tumor Growth and ApoptosisNeurochemical Research, 2025
- Cancers of the brain and central nervous system: global patterns and trends in incidenceJournal of Neuro-Oncology, 2025
- Diffuse, IDH-wildtype gliomas in adults with minimal histological change and isolated TERT promoter mutation: not simply CNS WHO grade 4Acta Neuropathologica, 2024
- A review of mechanisms underlying the protective effects of natural compounds against arsenic-induced neurotoxicityBioMetals, 2022
- Antioxidant Effect of Hydroxytyrosol, Hydroxytyrosol Acetate and Nitrohydroxytyrosol in a Rat MPP+ Model of Parkinson’s DiseaseNeurochemical Research, 2021
- Pharmacokinetics and bioavailability of hydroxytyrosol are dependent on the food matrix in humansEuropean Journal of Nutrition, 2020
- Functional morphology of the blood–brain barrier in health and diseaseActa Neuropathologica, 2018
- 3,4-Dihydroxyphenylethanol (Hydroxytyrosol) Mitigates the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 CellsNeurochemical Research, 2016